Biogen to discontinue development of older Alzheimer’s drug Aduhelm
(Reuters) – Biogen Inc said on Wednesday it would terminate a post-approval study of its first Alzheimer’s drug, Aduhelm, and discontinue all commercialization for the …
(Reuters) – Biogen Inc said on Wednesday it would terminate a post-approval study of its first Alzheimer’s drug, Aduhelm, and discontinue all commercialization for the …
(Reuters) – Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and …
ZURICH (Reuters) -Russia’s Gazprombank has decided to cease operating in Switzerland after “a strategic review of various options”, it said on Monday. The bank had …
Biden Admin Appears To Quietly Discontinue Offshore Leasing For Nearly Two Years, Budget Shows Thomas Catenacci on March 30, 2022 President Joe Biden’s budget framework …
– Exxon Mobil Corp said on Tuesday it is starting a process to discontinue operations and developing steps to exit the Sakhalin-1 venture in Russia. …